Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Coupaye, Muriel (24314690300)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity
    (2021)
    De Groot, Cornelis Jan (56878477100)
    ;
    Poitou Bernert, Christine (55908860000)
    ;
    Coupaye, Muriel (24314690300)
    ;
    Clement, Karine (7005043037)
    ;
    Paschou, Stavroula A. (55632917800)
    ;
    Charmandari, Evangelia (7004635158)
    ;
    Kanaka-Gantenbein, Christina (55886598900)
    ;
    Wabitsch, Martin (7005831598)
    ;
    Buddingh, Emilie P. (6506603238)
    ;
    Nieuwenhuijsen, Barbara (57221731510)
    ;
    Marina, Ljiljana (36523361900)
    ;
    Johannsson, Gudmundur (56214660100)
    ;
    Van Den Akker, E.L.T. (7003723270)
    This article aims to provide guidance on prevention and treatment of COVID-19 in patients with genetic obesity. Key principals of the management of patients with genetic obesity during COVID-19 pandemic for patients that have contracted COVID-19 are to be aware of: possible adrenal insufficiency (e.g., POMC deficiency, PWS); a more severe course in patients with concomitant immunodeficiency (e.g., LEP and LEPR deficiency), although defective leptin signalling could also be protective against the pro-inflammatory phenotype of COVID-19; disease severity being masked by insufficient awareness of symptoms in syndromic obesity patients with intellectual deficit (in particular PWS); to adjust medication dose to increased body size, preferably use dosing in m2; the high risk of malnutrition in patients with Sars-Cov2 infection, even in case of obesity. Key principals of the obesity management during the pandemic are to strive for optimal obesity management and a healthy lifestyle within the possibilities of the regulations to prevent weight (re)gain and to address anxiety within consultations, since prevalence of anxiety for COVID-19 is underestimated. © 2021, The Author(s).
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity
    (2021)
    De Groot, Cornelis Jan (56878477100)
    ;
    Poitou Bernert, Christine (55908860000)
    ;
    Coupaye, Muriel (24314690300)
    ;
    Clement, Karine (7005043037)
    ;
    Paschou, Stavroula A. (55632917800)
    ;
    Charmandari, Evangelia (7004635158)
    ;
    Kanaka-Gantenbein, Christina (55886598900)
    ;
    Wabitsch, Martin (7005831598)
    ;
    Buddingh, Emilie P. (6506603238)
    ;
    Nieuwenhuijsen, Barbara (57221731510)
    ;
    Marina, Ljiljana (36523361900)
    ;
    Johannsson, Gudmundur (56214660100)
    ;
    Van Den Akker, E.L.T. (7003723270)
    This article aims to provide guidance on prevention and treatment of COVID-19 in patients with genetic obesity. Key principals of the management of patients with genetic obesity during COVID-19 pandemic for patients that have contracted COVID-19 are to be aware of: possible adrenal insufficiency (e.g., POMC deficiency, PWS); a more severe course in patients with concomitant immunodeficiency (e.g., LEP and LEPR deficiency), although defective leptin signalling could also be protective against the pro-inflammatory phenotype of COVID-19; disease severity being masked by insufficient awareness of symptoms in syndromic obesity patients with intellectual deficit (in particular PWS); to adjust medication dose to increased body size, preferably use dosing in m2; the high risk of malnutrition in patients with Sars-Cov2 infection, even in case of obesity. Key principals of the obesity management during the pandemic are to strive for optimal obesity management and a healthy lifestyle within the possibilities of the regulations to prevent weight (re)gain and to address anxiety within consultations, since prevalence of anxiety for COVID-19 is underestimated. © 2021, The Author(s).

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback